Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
DGP 2023
Programm
Poster
Personen
Suche
EN
Alle Personen
Prof. Dr. Andrew Hemphill
Bern / CH
Institute of Parasitology, University of Bern
Sortiert nach Typ
Datum
Vorsitz
15.03.2023
14:45
–
16:15
Scientific Session
Drug Development/ Resistance
HS II (GF)
Vortrag
15.03.2023
15:15
–
15:30
10 Min.
5 Min.
Talk
A14
Differential affinity chromatography coupled to mass spectrometry: a 3R-relevant tool to identify common binding proteins of a broad-range antimicrobial peptide and potentially other compounds active against
Toxoplasma gondii
Drug Development/Target Identification, Parasite-Host Interaction
17.03.2023
14:30
–
14:45
10 Min.
5 Min.
Talk
A139
Proteomic characterization of
Toxoplasma gondii
ME49 derived strains resistant to the artemisinin derivatives artemiside and artemisone implies potential mode of action independent of ROS formation
Drug Development/Target Identification, Drug Resistance
Weitere Beteiligungen
15.03.2023
15:15
–
15:30
10 Min.
5 Min.
Talk
A14
Differential affinity chromatography coupled to mass spectrometry: a 3R-relevant tool to identify common binding proteins of a broad-range antimicrobial peptide and potentially other compounds active against
Toxoplasma gondii
Drug Development/Target Identification, Parasite-Host Interaction
16.03.2023
11:00
–
11:15
10 Min.
5 Min.
Talk
A43
A comparative proteomic analysis of
Toxoplasma gondii
RH wild-type and four SRS29B (SAG1) knock-out clones to understand the impact of
sag1
disruption on the gene expression profile during the lytic cycle
in vitro
Molecular Parasitology
17.03.2023
13:30
–
13:45
10 Min.
5 Min.
Talk
A129
Objective
in vitro
drug testing for
Echinococcus granulosus
Drug Development/Target Identification, One Health/NTD/Zoonoses
17.03.2023
14:30
–
14:45
10 Min.
5 Min.
Talk
A139
Proteomic characterization of
Toxoplasma gondii
ME49 derived strains resistant to the artemisinin derivatives artemiside and artemisone implies potential mode of action independent of ROS formation
Drug Development/Target Identification, Drug Resistance
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz